2022. Production of SARS-CoV-2 pseudotyped viral particles for the evaluation of new therapies against COVID-19. FAVE Sección Ciencias Veterinarias. 20, Suppl. (May 2022), 44–50. DOI:https://doi.org/10.14409/favecv.2021.Suppl. 44-50.